The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Blocking - Blocking peptide for Anti-MURF1 antibody (ab4125)
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
E3 ubiquitin-protein ligase TRIM63
Iris RING finger protein
Muscle specific ring finger protein 1
Muscle specific ring finger protein 2
Muscle-specific RING finger protein 1
RING finger protein 28
Striated muscle RING zinc finger protein
Tripartite motif containing 63
tripartite motif containing 63, E3 ubiquitin protein ligase
Tripartite motif containing protein 63
Tripartite motif-containing protein 63
Ubiquitin ligase TRIM63
E3 ubiquitin ligase. Regulates proteasomal degradation of cardiac troponin I/TNNI3 and probably of other sarcomeric-associated proteins. May play a role in striated muscle atrophy and hypertrophy by regulating an anti-hypertrophic PKC-mediated signaling pathway. May regulate the organization of myofibrils through TTN in muscle cells.
Muscle specific. Selectively expressed in heart and skeletal muscle. Also expressed in the iris.
Protein modification; protein ubiquitination.
Contains 1 B box-type zinc finger. Contains 1 COS domain. Contains 1 RING-type zinc finger.
Expressed throughout all developmental stages.
The RING-type zinc finger mediates interaction with SUMO2 and localization to the nucleus. Also required for the E3 ubiquitin ligase activity.
Cytoplasm. Nucleus. Localizes to the M- and Z-lines in skeletal muscle. Colocalizes with TNNI3 in myocytes.